- Home
- OCGN vs CADL Comparison
OCGN vs CADL Comparison
Compare OCGN & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- CADL
- Stock Information
- Founded
- OCGN 2013
- CADL 1999
- Country
- OCGN United States
- CADL United States
- Employees
- OCGN N/A
- CADL N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- OCGN Health Care
- CADL Health Care
- Exchange
- OCGN Nasdaq
- CADL Nasdaq
- Market Cap
- OCGN 321.7M
- CADL 339.8M
- IPO Year
- OCGN N/A
- CADL 2021
- Fundamental
- Price
- OCGN $1.52
- CADL $5.48
- Analyst Decision
- OCGN Strong Buy
- CADL Strong Buy
- Analyst Count
- OCGN 2
- CADL 7
- Target Price
- OCGN $7.00
- CADL $19.57
- AVG Volume (30 Days)
- OCGN 5.9M
- CADL 852.2K
- Earning Date
- OCGN 11-05-2025
- CADL 11-13-2025
- Dividend Yield
- OCGN N/A
- CADL N/A
- EPS Growth
- OCGN N/A
- CADL N/A
- EPS
- OCGN N/A
- CADL N/A
- Revenue
- OCGN $4,754,000.00
- CADL N/A
- Revenue This Year
- OCGN N/A
- CADL N/A
- Revenue Next Year
- OCGN N/A
- CADL N/A
- P/E Ratio
- OCGN N/A
- CADL N/A
- Revenue Growth
- OCGN N/A
- CADL N/A
- 52 Week Low
- OCGN $0.52
- CADL $3.79
- 52 Week High
- OCGN $1.90
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- OCGN 48.14
- CADL 48.58
- Support Level
- OCGN $1.47
- CADL $5.11
- Resistance Level
- OCGN $1.65
- CADL $5.80
- Average True Range (ATR)
- OCGN 0.11
- CADL 0.37
- MACD
- OCGN -0.03
- CADL -0.04
- Stochastic Oscillator
- OCGN 13.51
- CADL 24.66
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.